Last reviewed · How we verify

NCT03353519: IPCAS

Improving Primary Care After Stroke (IPCAS)

Completed NA Last updated 7 October 2021
What this trial tests

NA trial testing Primary care model in Stroke in 1,041 participants. Completed in 30 September 2020.

Timeline
30 April 2018
Primary endpoint
30 September 2020
30 September 2020

Quick facts

Lead sponsorUniversity of Cambridge
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment1,041
Start date30 April 2018
Primary completion30 September 2020
Estimated completion30 September 2020
Sites2 locations across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Cambridge

Who can join

18 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

No formal primary care based model of care exists to support stroke survivors living in the community. A large variation in the range, quality and access to health services offered to stroke survivors between and within local clinical commissioning groups suggests that many of the stroke survivors' needs are not being met systematically. Therefore, to address the longer term needs we have developed a multi-factorial primary care model that seeks to enable greater engagement with stroke care and community services, to link effectively to specialist services, and to improve the lives of stroke survivors. This will be a two-arm cluster randomised controlled trial. Participating general practices will be randomised to deliver either the new model of stroke care or current usual care. The aim of this trial will be to assess the clinical and long-term cost effectiveness of the new model of primary care for stroke survivors living in the community. The primary outcome for the trial will be measured using two sub-scales (emotion and handicap) of the Stroke Impact Scale questionnaire at 12 months.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Improving Primary Care After Stroke (IPCAS) trial: protocol of a randomised controlled trial to evaluate a novel model of care for stroke survivors living in the community.
    Mullis R, Aquino MRJR, Dawson SN, Johnson V, et al · · 2019 · cited 10× · PMID 31427339 · DOI 10.1136/bmjopen-2019-030285
  2. Patients' experience of and participation in a stroke self-management programme, My Life After Stroke (MLAS): a multimethod study.
    Blatchford EG, Aquino MRJ, Grant J, Johnson V, et al · · 2022 · cited 4× · PMID 36379661 · DOI 10.1136/bmjopen-2022-062700
  3. Improving Primary Care After Stroke (IPCAS) randomised controlled trial: protocol for a multidimensional process evaluation.
    Aquino MRJR, Mullis R, Kreit E, Johnson V, et al · · 2020 · cited 3× · PMID 32641334 · DOI 10.1136/bmjopen-2020-036879
  4. Implementing a new model of primary care for stroke survivors living in the community: a mixed-methods process evaluation.
    Aquino MRJ, Turner G, Kreit E, Blatchford EG, et al · · 2025 · PMID 40684242 · DOI 10.1186/s13063-025-08957-w
  5. Implementing a new model of primary care for stroke survivors living in the community: a mixed-methods process evaluation
    Aquino MRJ, Turner G, Kreit E, Blatchford EG, et al · · 2024 · DOI 10.21203/rs.3.rs-4559867/v1

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other University of Cambridge trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03353519.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing